Inventor profile of:

Alexandre Cote

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

26

Last publication date:

2024-04-11

Top Assignees for applications by Alexandre Cote

The entities that hold a legal rights for patent applications filed by inventor Cote Alexandre:

Recent patent applications by Cote Alexandre

Alexandre Cote from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-04-11
US20240116905A1
Chemistry; metallurgy

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

#2 | 2021-07-29
US20210230148A1
Chemistry; metallurgy

Modulators of methyl modifying enzymes, compositions and uses thereof

#3 | 2021-07-08
US20210206776A1
Chemistry; metallurgy

Modulators of methyl modifying enzymes, compositions and uses thereof

#4 | 2020-10-08
US20200317651A1
Chemistry; metallurgy

Modulators of methyl modifying enzymes, compositions and uses thereof

#5 | 2019-10-24
US20190322651A1
Chemistry; metallurgy

Modulators of methyl modifying enzymes, compositions and uses thereof

#6 | 2018-10-11
US20180290976A1
Chemistry; metallurgy

LSD1 inhibitors and uses thereof

#7 | 2018-03-29
US20180086720A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#8 | 2018-02-08
US20180037566A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#9 | 2018-01-25
US20180022727A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#10 | 2018-01-25
US20180022707A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#11 | 2018-01-11
US20180009735A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#12 | 2017-11-30
US20170342067A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#13 | 2017-11-30
US20170340605A1
Human necessities

Therapeutic compounds and uses thereof

#14 | 2017-11-30
US20170340604A1
Human necessities

Therapeutic compounds and uses thereof

#15 | 2017-11-23
US20170334883A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#16 | 2017-11-23
US20170333406A1
Human necessities

THERAPEUTIC COMPOUNDS AND USES THEREOF

#17 | 2017-11-02
US20170312292A1
Human necessities

Therapeutic compounds and uses thereof

#18 | 2017-09-28
US20170275289A1
Chemistry; metallurgy

Therapeutic compounds and uses thereof

#19 | 2016-11-03
US20160317632A1
Human necessities

USE OF CBP/EP300 BROMODOMAIN INHIBITORS FOR CANCER IMMUNOTHERAPY

#20 | 2016-06-09
US20160158207A1
Human necessities

Therapeutic compounds and uses thereof

#21 | 2016-01-28
US20160024504A1
Chemistry; metallurgy

TREATING TH2-MEDIATED DISEASES BY INHIBITION OF BROMODOMAINS

#22 | 2016-01-14
US20160009718A1
Chemistry; metallurgy

Modulators of methyl modifying enzymes, compositions and uses thereof

#23 | 2014-12-18
US20140371206A1
Chemistry; metallurgy

Bromodomain inhibitors and uses thereof

#24 | 2014-10-02
US20140296243A1
Chemistry; metallurgy

Bromodomain inhibitors and uses thereof

#25 | 2014-01-02
US20140005169A1
Chemistry; metallurgy

Bromodomain inhibitors and uses thereof

#26 | 2012-06-21
US20120157428A1
Chemistry; metallurgy

Bromodomain inhibitors and uses thereof

InventorID:

597288 ⎘